Efficacy and safety of opicinumab in participants with relapsing multiple sclerosis: a randomized, placebo-controlled, phase 2 trial (AFFINITY part 1)
Dual GLP-1/GIP receptor agonists are currently being explored as an advanced approach to treat diabetes and obesity, aiming to enhance insulin release and reduce the risk of diabetes-related complications even further
doi:10.1186/s12944-018-0779-4
Diet remains the most reliable way to build antioxidant intake, and habits like regular exercise, adequate sleep, and quitting smoking work alongside it
First authorised by the US Food and Drug Administration in May 2022, Mounjaro became available in the UK following MHRA approval in October 2022
Instead, it refers to achieving a healthier, brighter, and more uniform complexion by reducing excess pigmentation, tanning, and dullness